Understanding Ilaris: A Breakthrough in Treating Autoimmune and Inflammatory Conditions Ilaris (canakinumab) is a revolutionary biologic medication developed by Novartis, specifically designed to manage several rare and severe inflammatory and autoimmune diseases. As a fully human monoclonal antibody targeting interleukin-1 beta (IL-1β), Ilaris effectively reduces inflammation, making it a...